Development of a New Canadian Endourology Group Stent Symptom Score

Launched by CENTRE HOSPITALIER DE L'UNIVERSITÉ DE MONTRÉAL (CHUM) · May 28, 2021

Keywords

ClinConnect Summary

This clinical trial is focused on creating a new tool called the Canadian Endourology Group Stent Symptom Score (CEGSSS). This tool aims to help doctors better understand how ureteral stents, which are small tubes placed in the urinary system to help with drainage, affect patients' quality of life. Currently, there is no effective way to measure the discomfort or issues that patients experience from having these stents, which makes it hard for doctors to improve patient care. The study will take place in three phases, starting with gathering input from patients and doctors about what questions should be included in the new score. Then, a pilot study will test the score, followed by a larger study to confirm its accuracy and usefulness.

To participate in this trial, you need to be at least 18 years old and currently have a ureteral stent. You should also be able to communicate in English. If someone has an active cancer diagnosis, struggles with understanding the study, or has had a stent for more than two weeks, they may not be eligible to join. Participants will be involved in the development of this important tool, which aims to make life easier for many people who need ureteral stents.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Age ≥ 18 years
• • Patient with ureteral stent
• • Ability to communicate in English
• Exclusion Criteria:
• • Inability to provide an informed consent due to physical or mental inability
• • Active malignancy
• • Obstruction
• • Long-term stent (\>2 weeks)